Groups | Patients, n(%) | GG | GT | TT |
---|---|---|---|---|
Cancer | ||||
ERβ–positive | 698/855 (81.64) | 226 /265 (85.28) | 350 /410 (85.37) | 122/180 (67.78) |
Fibroadenoma | ||||
ERβ–positive | 550/628 (87.58) | 205/235 (87.23) | 266/304 (87.50) | 79/89 (88.76) |
OR | 0.631 | 0.848 | 0.858 | 0.266 |
CI 95% | 0.470–0.846 | 0.508–1.415 | 0.556–1.324 | 0.129–0.552 |
p value | 0.002 | 0.528 | 0.49 | <0.001 |